FAST Australia is committed to advancing Australian research while maintaining a strong collaborative relationship with FAST United States and global patient organisations.
We focus our efforts on determining areas of unmet Angelman syndrome research in line with the global vision for a cure and identify opportunities to fund research to address those gaps. Read more about how/where we have invested funds in research below.

Enabling

Tools & resources that will allow research into our ultimate goal to progress.

Enabling

Learning

Basic science that will help us understand more about the syndrome to propel research.

  • RNA binding motifs as therapeutic targets for Angelman syndrome (University of Sydney)
  • Expression profiling for mechanisms of minocycline action (Queensland Bioinformatics)
  • Health Economics in Angelman syndrome
  • Incidence of Food Sensitivity and Gut Dysbiosis in Angelman syndrome
    (Co-funded with FAST United States and FAST United Kingdom)

Treatments

Discovering therapeutics that alleviate one or more symptoms of Angelman syndrome

Learning